Publications

Dr. Wendy Book

Book WM, Hott BJ. Beta-adrenergic receptor blockers in heart failure. Curr Treat Options Cardiovasc Med 2003;5(6):475-485.

Greenberg JM, Leon AR, Book WM, et al. Benefits of resynchronization therapy in outpatients with indicators for heart transplantation. J Heart Lung Transplant 2003;22(10):1134-40.

Book WM, Kelly L, Gravanis MB Fulminant Mixed Humoral and Cellular Rejection in a Cardiac Transplant Recipient. A review of the Histological Findings and Literature. J Heart Lung Transplant 2003; 221(5): 604-7

Gradek WQ, D’Amico C, Smith AL, Vega D., Book, WM. Routine surveillance endomyocardial biopsy continues to detect significant rejection late after heart transplantation. J Heart Lung Transplant. 2001 May; 20 (5): 497-502. PMID: 11343975

Dempsey SJ, D’Amico C., Weintraub WS, Lutz J, Smith AL, Ghazzal ZM, Book WM. Angiographic and clinical follow-up of percutaneous revascularization for transplant coronary artery disease. J Invasive Cardiol. 2000 June; 12 (6):311-5. PMID: 10859717

Book WM, Raviele AA, Vincent RN. Transhepatic Vascular Access in Pediatric Cardiology Patients with Occlusion of Traditional Central Venous Sites. J. Invasive Cardiol. 1999; Jun 11 (6): 341-344. PMID: 10745545

Book WM, Raviele AA, Vincent RN. Repetitive percutaneous transhepatic access for myocardial biopsy in pediatric cardiac transplant recipients. Cathet Cardiovasc Diagn. 1998; Oct 45 (2): 167-9 PMID: 9786397

Baker C, Book WM, Martin R, Klein L, Causey RL, Smith A. Narrow QRS duration predicts improved ejection fraction on Carvedilol. Journal of Cardiac Failure Vol. 6, No. 3, Suppl. 2, 2000

Gradek WQ, D’Amico C, Vega D, Smith AL, Book WM. Routine surveillance endomyocardial biopsy continues to detect significant rejection late after heart transplantation. Transplantation. 2000; 69 (8): S271
Vega JD, Buist N, Chestnut N, Smith AL, Book WM, Kanter KR. Can the Implementation of critical pathways affect outcomes after heart transplantation? J. of Heart and Lung Transplant 2000: 19(1)

Deaton C, Jacobson L, Causey RL, Huddleson A, Mehlan R, Anderson D, Hitchcock M, Connolly S, Book W, Smith AL. Reversing the trend: Improvement in resource utilization, quality of life and self-care in patients referred to an advanced heart failure clinic. . 1999: Circ 100 (18)S1: 1-100

Book Chapters:
“Heart Failure in Women”, Book WM, Hott, BJ, Vaccarino V. In: Tailored Heart Failure Therapy. Willenheimer & Swedberg. Martin-Duntz 2002

Book WM, “Congenital Heart Disease”. In: Branch WT, Cardiology in primary Care. New York. McGraw-Hill; 2000

Smith AL, Book WM, The Heart and Noncardiac Drugs, Electricity, Poisons, and Radiation. In: Alexander, Schlant, Fuster, O’Rourke, Roberts, Sonnenblick: Hurst’s The Heart, 11th Edition (in press). New York: McGraw-Hill; 2003

Tirrito SJ, Miller III, J, Sperling L, Book WM. Hypertriglyceridemia as a marker of risk for arteriopathy in the post cardiac transplant recipient. 8th World Congress of Heart Failure. July 2002

Dr. J. David Vega

Trachiotis GD, Kanter KR, Vega JD, Crocker IR, Smith AL, Johnston TS, Chesnut N, Lutz JF. Single field total lymphoid irradiation (TLI) in the treatment of refractory rejection following heart transplantation. J Heart and Lung Transplant 16(1):96, 1997

Trachiotis G, D’Amico C, Johnston T, Smith A, Lutz J, Vega JD, Kanter K. Short or long term support with Novacor left ventricular assist device provides an effective bridge to transplantation. Am Soc Artif Intern Organs 43:2, p 37, 1997

Trachiotis GD, Sathavorn CS, Smith AL, Kanter KR, Vega JD, Lutz JF, Vincent RN, Berg A, Gravanis MB, Johnston TS: Chronic methotrexate therapy for recurrent rejection after heart transplantation. Proceedings, 16th Annual Meeting Amer Soc of Transplant Physicians, Chicago, IL, p 209, May 1997

Trachiotis GD, Kanter KR, Vega JD, Berg A, Whelchel J, Smith AL, Johnston TS, Lutz JF: Five year follow-up in patients with combined heart and kidney transplantation. Proceedings, 23rd Annual Scientific Meeting Amer Soc of Transplant Surgeons, Chicago, IL, p A-298, May 1997

Vega JD, Kanter KR, Trachiotis GD, D’Amico CL, Smith Al, Johnston TS, Lutz JF: Outpatient OKT3 for cardiac allograft rejection - Is it safe and cost effective? Transplantation 65(8)(Suppl):233, 1998

Vega D, Jeevanandam V, Ochsner J, Womble D, Schroeder TJ: A prospective randomized multicenter trial comparing Celsior® to standard cardiac preservation solutions. Transplantation 65(8)(Suppl):95, 1998

Smallwood GA, Perlino CA, Vega JD, Heffron TC, Stieber AC, Gordon RG: Comparison of pre-emptive therapy based on PCR with prophylaxis for preventation of CMV disease occurrence in high risk transplant patients. Transplantation 65(8)(Suppl):190, 1998

Vega D, Berg A, Womble D: Preliminary results of a prospective randomized multicenter trial comparing Celsior® to standard preservation solutions for cardiac transplantation. Denton A. Cooley Cardiovascular Surgical Society 11th International Symposium, Colorado Springs, CO, p 28, August 1998

Vega JD, Levy JH, Buist NN, Allen MB, Smith AL, Lu W, Kanter K: Does warfain increase bleeding in patients undergoing heart transplantation? Transplantation 67(7)(Suppl):105, 1999

Vega JD, Stringham JD, Staples ED: A prospective randomized multicenter trial comparing Celsior® to standard preservation solution. Transplantation 67(9)(Suppl):653, 1999

Bray RA, D’Amico CL, Kanter KR, Smith AL, Wilmoth-Hosey L, Berg A, Vega JD: FlowPRA™, flow cytometric crossmatch and HLA-DR matching are predictors of early rejection episodes in cardiac transplantation. J Heart and Lung Transplant 19(1):39, 2000

Vega JD, Staples ED, McGiffin DC, Stringham JC: A comparison of Celsior® to standard cardiac preservation solutions for cardiac transplantation with high-risk donors. J Heart and Lung Transplant 19(1):77, 2000

Kanter KR, Berg AM, Bray RA, Vincent RN, D’Amico CL, Holcomb JE, Vega JD: Positive retrospective crossmatch after pediatric heart transplantation--Should we worry? J Heart and Lung Transplant 19(1):84, 2000

Gradek QW, D’Amico C, Vega D, Smith AL, Book WM: Routine surveillance endomyocardial biopsy continues to detect significant rejection late after orthotopic heart transplantation. Transplantation 69(8):S271, 2000

Haselden AE and Vega JD: Successful explantation of the Thoratec biventricular assist device in a patient with acute viral myocarditis. Syllabus for the 15th Annual Meeting of the American Association of Cardiovascular and Pulmonary Rehabilitation, Tampa, FL, p 556, September 2000

Hasleden AE, McTeague KK, Vega JD: Case Report: Efficacy of the six minute walk test to document a training effect in a patient supported with the Thoratec Biventricular Assist Device. AACVPR Syllabus , p 466, September 2001

Chen EP, Tam VKH, Vega JD: Chronic aortic dissection is not a contraindication to orthotopic cardiac transplantation. 13th International Symposium of the Denton A. Cooley Cardiovascular Surgical Society, Carlsbad, CA, July 2002

Dr. Andrew Smith

Abstracts:
Greenberg JA, Leon AR, DeLurgio DB, Langberg JJ, Hott BJ, Book WM, Smith AL. Cardiac resynchronization therapy markedly reduces the need for heart transplantation. J Heart Lung Transplant 2002;21(1):125.

Jarcho J, Brown RN, Brown BK, Smith AL, Herre JM, Smart F, Clemson BS, Pritzker MR, Tsiang S, Kirklin JK. Cardiac Transplant Research Database (CTRD), fatal rejection after cardiac transplantation: risk factors and ERA effects from a 10-year multiinstitutional analysis. J Heart Lung Transplant 2002;21(1):55-56.

S. Kushwaha, Rodeheffer RJ, Weiss, T, Jarcho J, Pritzker M, Smith AL, Heilman KJ, Clemson BS, Rayburn BK, Bourge R, Kirklin J. Longer distance from transplant center is not associated with decreased survival in post cardiac transplant patients. J Heart Lung Transplantation 2001;20(2):236-237.

Bray RA, D’Amico C L, Kanter KR, Smith AL, et al. Flow Cytometric Crossmatch and HLA-DR Matching are Predictors of Early Rejection Episodes in Cardiac Transplantation. J Heart Lung Transplant Jan 2000; 19(1):39.

Lake KD, Smith CI, Pritzker MR, Renlund DE, Heilman JK, Smith AL, Miller LW, Weiss LT , Kirklin J K, Bourge R C, and the Cardiac Transplant Research Database (CTRD). Outcomes with Hepatitis C Following Cardiac Transplantation – A Multi-Institutional Study. J Heart Lung Transplant 1999;18:81.

Vega JD, Levy JH, Buist NN, Allen MB, Smith AL, Lu W, Kanter K. Does warfarin increase bleeding in patients undergoing heart transplantation? Transplantation 1999; 67(7)(Suppl):105.

Vega JD, Kanter KR, Trachiotis G D, D’Amico CL, Smith AL, Johnston TS, Lutz J F. Outpatient OKT3 for cardiac allograft rejection – Is it safe and cost effective? Transplantation 1998; 65(8)(Suppl):95.

Trachiotis G D, Sathavorn C S, Smith A L, Kanter K R, Vega J D, Lutz J F, Vincent R N, Berg A, Gravanis M B, Johnston T S. Chronic methotrexate therapy for recurrent rejection after heart transplantation. Proceedings, 16th Annual Meeting Amer Soc of Transplant Physicians, Chicago, IL, p 209, May 1997.

Trachiotis G D, Kanter K R, Vega J D, Berg A, Whelchel J, Smith A L, Johnston T S, Lutz J F. Five-year follow-up in patients with combined heart kidney transplantation. Proceedings, 23rd Annual Scientific Meeting Amer Soc of Transplant Surgeons, Chicago, IL, p A-298, May 1997.

Smith A.L, Felkel T, Lutz J F, Kanter, K R, Gravanis M B, Johnston T S. The Importance of Surveillance Myocardial Biopsies in the Detection of Unsuspected Rejection Beyond One Year After Cardiac Transplantation. J Heart Lung Transplant ; 16 (1): 79, Jan 1997.

Trachiotis GD, Johnston TS, Vega J D, Crocke, I R, Johnston T S, Chestnut N, Lutz J, Smith A L, Kanter K. Single Field total lymphoid irradiation (TLI) in the Treatment of Refractory rejection following heart transplantation. J Heart Lung Transplant ; 16 (1): 96, Jan 1997.

Trachiotis D, D’Amico C, Johnston T, Smith A, Lutz J, Vega J D, Kanter K. Short or long term support with Novacor left ventricular assist device provides an effective bridge to transplantation. Am Soc Artif Intern Organs 1997; 43:2, p 37.

Smith A.L., Tallarida R.J., Bove A.A., Arterial denervation and cyclosporine therapy diminish endothelium-dependent relaxation. JACC 15 (2): 230A, March, 1990.

Smith A.L., Tallarida R.J., Bove A.A. Denervation inhibits endothelium-dependent relaxation in rabbit aorta. Clinical Research 37 (2), 297 A, April 1989.

Smith A.L., Goldschmidt J., Tallarida R.J., Effect of temperature on agonist and antagonist adrenoceptor dissociation constant on isolated rings of rabbit aorta. FASEB May 1988;Journal 2, 8814.

Journal Articles:
Trachiotis GD, Vega JD, Johnston TS, Berg A, Whelchel J, Smith AL, Lutz J, Kanter KR. Ten-year follow-up in patients with combined heart and kidney transplantation. J Thor Cardiovas Surg. 126(6):2065-71, 2003 Dec.

Greenberg JM, Leon AR, Book WM, Hott BJ, Delurgio DB, Langberg JJ, Smith AL. Benefits of cardiac resynchronization therapy in outpatients with indicators for heart transplantation. J Heart Lung Trans. 22(10):1134-40, 2003 Oct.

Felkel TO, Smith AL, Reichenspurner HC, LaFleur B, Lutz JF, Kanter KR, Gravanis MB, Johnston TS. . Survival and incidence of acute rejection in heart transplant recipients undergoing successful withdrawal from steroid therapy. J Heart Lung Transplant May 2002; 21 (5):503-539.

Morris CD, Vega JD, Levy JH, Buist NN, Smith AL, Despotis GJ, Kanter KR. Warfarin therapy does not increase bleeding in patients undergoing heart transplantation. Ann Thor Surg Sep 2001; 72(3):714-8.

Gradek WQ, D’Amico C, Smith AL, Vega D, Book WM. Routine surveillance endomyocardial biopsy continues to detect significant rejection late after heart transplantation. J Heart Lung Transplant May 2001; 20(5):497-502.

Eisen HJ, Hobbs RE, Davis SF, Carrier M, Mancini DM, Smith A, Valantine H, Ventura H, Mehra M, Vachiery JL, Rayburn BK, Canver CC, Laufer G, Costanzo MR, Copeland J, Dureau G, Frazier OH, Dorent R, Hauptman PF, Kells C, Masters R, Michaud JL, Paradis I, Renlund DG, Vanhaecke J, Mellein B, Mueller EA. Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine – results at 24 months after transplantation. Transplantation Jan 15;71(1):70-8.

Dempsey SJ, D’Amico C, Weintraub WS, Lutz J, Smith AL, Ghazzal ZM, Book WM. Angiographic and clinical follow-up of percutaneous revascularization for transplant coronary artery disease. J Invasive Cardio Jun 2000; 12(6):311-5.

Tambur AR, Bray RA, Takemoto SK, Mancini M, Costanzo MR, Kobashingawa JA, D’Amico CL, Kanter KR, Berg A, Vega JD, Smith AL, Roggero AL, Ortegel JW, Wilmoth-Hosey L, Cecka JM, Gebel HM. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Transplantation Oct 2000; 70(7):1055-9.

Eisen HJ, Hobbs RE, David SF, Laufer G, Mancini DM, Renlund DG, Valantine H, Ventura H, Vachiery JL, Bourge RC, Canver CC, Carrier M, Costanzo MR, Copeland J, Durean G, Frazier O H, Dorent R, Hauptman PF, Kells C, Master R, Michaud JL, Paradis I, Smith A, Vanhaecke J, Mueller EA. Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison wit the oil based formulation of cyclosporine results at six months after transplantation. Transplantation Sep 1999; 68(5):663-7.

Trachiotis GD, Johnston TS, Vega J D, Crocker I R, Chesnut N, Lutz J F, Smith A L, Kanter K R. Single-field total lymphoid irradiation in the treatment of refractory rejection after heart transplantation. J Heart Lung Transplant Nov 1998; 17 (11):1045-1048.

Kanter KR, Vega JD, Smith AL. Heart transplantation – current perspectives. J Med Asso. GA 1998; 87(2):141-144.

Morley D, Boigon M, Fesniak H, Brubaker P, Walter J, Fitzpatrick J, Chojnowski D, Smith A, Alpern J, Brozena S. Post transplantation hemodynamics and exercise function are not affected by body size matching of donor and recipient. J Heart Lung Transplant 1993;12 (5):770-778.

Book Chapters:
Smith A L, Brozena S C. Cardiac Transplantation in Women. In: Julian and Wenger; Women and Heart Disease. London: Martin Dunitz; 1996.